Liberty Biopharma (CVE:LTY) Stock Crosses Below Two Hundred Day Moving Average – Should You Sell?

Shares of Liberty Biopharma Inc (CVE:LTY) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares.

Liberty Biopharma Stock Performance

The company has a market capitalization of C$21.54 million and a price-to-earnings ratio of -12.66. The firm has a fifty day simple moving average of C$2.00 and a 200 day simple moving average of C$2.00. The company has a debt-to-equity ratio of 8.19, a current ratio of 0.12 and a quick ratio of 0.12.

Liberty Biopharma Company Profile

Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.